Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Bliss GVS Pharma Ltd

NSE: BLISSGVS · BSE: 506197 · Pharmaceuticals & Biotechnology · 40 announcements

Share price
₹681.55
Market cap
₹7,247 Cr
Revenue (annual)
₹927.1 Cr
Net profit (annual)
₹129.1 Cr
P/E (TTM)
53.2×Sector 47.3×
Promoter holding
35.01%-0.35% QoQ
FII holding
8.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:58 IST BSE
Other Announcement

Bliss GVS Pharma Other Announcement

Bliss GVS Pharma is transferring unclaimed dividends from 2018-2019 and related shares to the IEPF. Shareholders are notified to claim these funds by October 27, 2026.

13:54 IST BSE
Other Announcement

Bliss GVS Pharma Other Announcement

Bliss GVS Pharma updated contact details for KMPs authorized to determine and report material events. This administrative update ensures compliance with SEBI LODR Regulation 30(5).

16:31 IST BSE
Other Announcement

Bliss GVS Pharma Other Announcement

Bliss GVS Pharma submitted its Annual Secretarial Compliance Report for FY2026. The report details governance adherence and provides updates on previous regulatory non-compliance matters.